Atorvastatin Calcium
Product Images NDC 68071-4301

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4301 09

Label for Atorvastatin Calcium 10mg tablets by NuCare Pharmaceuticals, Inc., containing 90 tablets. The label includes the NDC number 68071-4301-9, indicates prescription only (Rx Only), and provides storage instructions to store at controlled temperature 59-86°F. The manufacturer is Apotex Inc., Toronto, Ontario, Canada, with packaging by NuCare Pharmaceuticals in Orange, CA. The label also includes warnings to keep out of reach of children and advises consulting a doctor for side effects.*

FDA Label Image

Figure-01 (Figure 01)

A line graph comparing the cumulative incidence percentage over a period of up to 3.5 years between Atorvastatin and a Placebo. The graph shows separate trend lines for Atorvastatin and Placebo, with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005 indicated at the bottom.*

FDA Label Image

Figure-02 (Figure 02)

A cumulative hazard graph comparing Atorvastatin and placebo groups over four years. The x-axis represents time in years to the first primary endpoint, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio data (HR 0.63) with confidence intervals and a p-value indicating statistical significance.*

FDA Label Image

Figure-03 (Figure 03)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over five years between Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to the first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The 10 mg dose shows a slightly higher event rate than the 80 mg dose over time.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium, showing the molecular arrangement of the active ingredient. The diagram illustrates the specific chemical bonds and elemental makeup for atorvastatin calcium in its calcium salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.